LloydsPharmacy goes into liquidation owing £293mLloydsPharmacy has entered into liquidation, concluding the final stage of its year-long divestment campaign under private equity owner Aurelius.
The pharmacy group appointed Martin Armstrong and Andrew Bailey of Turpin Barker Armstrong Accountants on January 16 to handle the proceedings.
In its statement of affairs report, the liquidators revealed that the pharmacy business owes £293m to 514 creditors.
This includes £228m owed to former LloydsPharmacy owner Admenta UK, with £50m owed to Aurelius Crocodile – a holding company used to control the business.
However, the liquidators said just £8.2m of assets can be recovered for LloydsPharmacy’s “preferential creditors” and £800,000 for its unsecured creditors.
LloydsPharmacy was sold to investment firm Aurelius UK in 2021 for £477m. At the time, the healthcare chain employed more than 2,500 pharmacists at almost 1,300 pharmacies.
The notice to appoint liquidators follows a year-long divestment campaign of its store estate of 1,054 high street and community pharmacies.
The programme concluded on November 26 when the pharmacy retailer exited the high street.
LloydsPharmacy’s holding company Hallo Healthcare said the pharmacies were “bought individually or in regional packages” by “independent pharmacy owners and local entrepreneurs”.
It added that over 6,500 branch colleagues were transferred across the branches were sold.
The healthcare chain’s owner began offloading its store estate early last year shortly after it announced it was shuttering all 237 of its branches inside Sainsbury’s in response to what it termed as “changing market conditions”.
Lloydspharmacy chief executive Kevin Birch stepped down from the business in May after just eight months at the helm.
His departure was joined by the sale of Hallo Healthcare’s private travel clinic company Masta to Irish-led travel group Nomad Travel.
A spokesperson for Hallo Healthcare Group said: “Whilst it may have left the high street, the LloydsPharmacy brand name and heritage remains in specialist pharmacy, clinical and digital healthcare.”